Latest Breaking News On - Public health solutions - Page 11 : comparemela.com

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease In Nonhuman Primate Models Of Ebola And Marburg Viruses

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease In Nonhuman Primate Models Of Ebola And Marburg Viruses
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of hawaii at manoaOreola doniniAxel lehrerExchange commissionJohna burns school medicineNational institute of allergyPrnewswire soligenix incUs congressUniversity of hawaiDepartment of tropical medicineSoligenix incDevelopment authorityCenters for diseaseJohna burns school of medicineCompany public health solutions

NYC Synagogue Launches World s First HIV Prevention Training Program For Jewish Clergy

NYC Synagogue Launches World s First HIV Prevention Training Program For Jewish Clergy
tabletmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tabletmag.com Daily Mail and Mail on Sunday newspapers.

Jewish theological seminaryNew yorkUnited statesDavid dunn bauerYeshivat chovevei torahBronwen mullinYork city department of healthFaith based initiativePublic health solutionsYork city councilNew york city basedCongregation beitSimchat torahNew york cityOpen orthodoxRabbi david dunn bauer

HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma Published in Frontiers in Drug Discovery

HyBryte™ has potential to address a critical gap in treatment of early-stage CTCL PRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on.

Brian poligoneRichard straubePrnewswire soligenix incRochester skin lymphoma medical groupUs developmentNational institute of allergyDefense threat reduction agencyUs congressSoligenix incOur public health solutionsEuropean medicines agencyDevelopment authorityBiomedical advanced researchExchange commissionSenior vice presidentChief medical officer

Soligenix Receives FDA IND Clearance For Phase 2 Clinical Trial Of Dusquetide In The Treatment Of Aphthous Ulcers In Behçet s Disease

Soligenix Receives FDA IND Clearance For Phase 2 Clinical Trial Of Dusquetide In The Treatment Of Aphthous Ulcers In Behçet s Disease
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomRobert hancockChristopherj schaberB brett finlayPrnewswire soligenix incUniversity of british columbiaNational institute of allergyExchange commissionDrug administrationUs developmentOur public health solutionsDefense threat reduction agencyUs congressBiomedical advanced researchDevelopment authoritySoligenix inc

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet s Disease

Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and.

United kingdomB brett finlayChristopherj schaberRobert hancockDevelopment authorityExchange commissionBiomedical advanced researchOur public health solutionsUs developmentUs congressPrnewswire soligenix incUniversity of british columbiaNational institute of allergyDefense threat reduction agencySoligenix incDrug administration